vs

Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $26.6M, roughly 1.8× NeuroPace Inc). NeuroPace Inc runs the higher net margin — -10.3% vs -468.9%, a 458.7% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs -22.4%). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs -10.9%).

Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

CMTG vs NPCE — Head-to-Head

Bigger by revenue
CMTG
CMTG
1.8× larger
CMTG
$46.7M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+46.2% gap
NPCE
23.9%
-22.4%
CMTG
Higher net margin
NPCE
NPCE
458.7% more per $
NPCE
-10.3%
-468.9%
CMTG
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
-10.9%
CMTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMTG
CMTG
NPCE
NPCE
Revenue
$46.7M
$26.6M
Net Profit
$-219.2M
$-2.7M
Gross Margin
77.4%
Operating Margin
-6.6%
Net Margin
-468.9%
-10.3%
Revenue YoY
-22.4%
23.9%
Net Profit YoY
-117.7%
48.0%
EPS (diluted)
$-1.56
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMTG
CMTG
NPCE
NPCE
Q4 25
$46.7M
$26.6M
Q3 25
$46.1M
$27.4M
Q2 25
$51.6M
$23.5M
Q1 25
$43.4M
$22.5M
Q4 24
$60.2M
$21.5M
Q3 24
$64.9M
$21.1M
Q2 24
$64.5M
$19.3M
Q1 24
$58.8M
$18.1M
Net Profit
CMTG
CMTG
NPCE
NPCE
Q4 25
$-219.2M
$-2.7M
Q3 25
$-9.5M
$-3.5M
Q2 25
$-181.7M
$-8.7M
Q1 25
$-78.6M
$-6.6M
Q4 24
$-100.7M
$-5.3M
Q3 24
$-56.2M
$-5.5M
Q2 24
$-11.6M
$-7.5M
Q1 24
$-52.8M
$-8.9M
Gross Margin
CMTG
CMTG
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
CMTG
CMTG
NPCE
NPCE
Q4 25
-6.6%
Q3 25
-9.5%
Q2 25
-29.0%
Q1 25
-22.9%
Q4 24
-17.0%
Q3 24
-20.1%
Q2 24
-32.4%
Q1 24
-41.6%
Net Margin
CMTG
CMTG
NPCE
NPCE
Q4 25
-468.9%
-10.3%
Q3 25
-20.7%
-12.8%
Q2 25
-351.9%
-36.8%
Q1 25
-181.3%
-29.3%
Q4 24
-167.2%
-24.5%
Q3 24
-86.7%
-25.9%
Q2 24
-17.9%
-39.0%
Q1 24
-89.7%
-49.2%
EPS (diluted)
CMTG
CMTG
NPCE
NPCE
Q4 25
$-1.56
$-0.08
Q3 25
$-0.07
$-0.11
Q2 25
$-1.30
$-0.26
Q1 25
$-0.56
$-0.21
Q4 24
$-0.72
$-0.16
Q3 24
$-0.40
$-0.19
Q2 24
$-0.09
$-0.26
Q1 24
$-0.39
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMTG
CMTG
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$173.2M
$61.1M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$1.5B
$19.0M
Total Assets
$4.7B
$105.6M
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMTG
CMTG
NPCE
NPCE
Q4 25
$173.2M
$61.1M
Q3 25
$339.5M
$60.0M
Q2 25
$209.2M
$62.1M
Q1 25
$127.8M
$66.3M
Q4 24
$99.1M
$52.8M
Q3 24
$113.9M
$56.8M
Q2 24
$148.2M
$55.5M
Q1 24
$232.5M
$58.9M
Total Debt
CMTG
CMTG
NPCE
NPCE
Q4 25
$3.2B
Q3 25
$3.7B
Q2 25
$4.0B
Q1 25
$4.7B
Q4 24
$4.9B
Q3 24
$5.1B
Q2 24
$5.3B
Q1 24
$5.5B
Stockholders' Equity
CMTG
CMTG
NPCE
NPCE
Q4 25
$1.5B
$19.0M
Q3 25
$1.7B
$18.5M
Q2 25
$1.8B
$19.4M
Q1 25
$1.9B
$24.3M
Q4 24
$2.0B
$8.0M
Q3 24
$2.1B
$9.8M
Q2 24
$2.2B
$9.9M
Q1 24
$2.2B
$14.3M
Total Assets
CMTG
CMTG
NPCE
NPCE
Q4 25
$4.7B
$105.6M
Q3 25
$5.4B
$107.3M
Q2 25
$5.8B
$106.1M
Q1 25
$6.7B
$110.2M
Q4 24
$7.0B
$94.6M
Q3 24
$7.3B
$96.3M
Q2 24
$7.6B
$94.4M
Q1 24
$7.8B
$98.9M
Debt / Equity
CMTG
CMTG
NPCE
NPCE
Q4 25
2.06×
Q3 25
2.09×
Q2 25
2.29×
Q1 25
2.42×
Q4 24
2.44×
Q3 24
2.44×
Q2 24
2.46×
Q1 24
2.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMTG
CMTG
NPCE
NPCE
Operating Cash FlowLast quarter
$-30.5M
$506.0K
Free Cash FlowOCF − Capex
$409.0K
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMTG
CMTG
NPCE
NPCE
Q4 25
$-30.5M
$506.0K
Q3 25
$8.8M
$-1.9M
Q2 25
$-5.8M
$-2.1M
Q1 25
$-35.8M
$-7.5M
Q4 24
$84.5M
$-4.8M
Q3 24
$39.2M
$-1.7M
Q2 24
$5.5M
$-3.9M
Q1 24
$21.5M
$-7.5M
Free Cash Flow
CMTG
CMTG
NPCE
NPCE
Q4 25
$409.0K
Q3 25
$-2.0M
Q2 25
$-2.3M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-1.8M
Q2 24
$-4.0M
Q1 24
$-7.6M
FCF Margin
CMTG
CMTG
NPCE
NPCE
Q4 25
1.5%
Q3 25
-7.2%
Q2 25
-9.6%
Q1 25
-33.4%
Q4 24
-22.5%
Q3 24
-8.7%
Q2 24
-20.6%
Q1 24
-42.1%
Capex Intensity
CMTG
CMTG
NPCE
NPCE
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.5%
Q2 24
0.3%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMTG
CMTG

Real Estate Owned Portfolio$34.2M73%
Other$11.1M24%
Mixed Use Property Fixed Rents$1.4M3%

NPCE
NPCE

Segment breakdown not available.

Related Comparisons